Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Life Sciences Année : 2015

Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity

Résumé

More than one million new cases of breast cancer are diagnosed worldwide each year and more than 400,000 deaths are caused by the disease. The origin of this pathology is multifactorial and involved genetic, hormonal, environmental and nutritional factors including obesity in postmenopausal women. The role played by the adipose tissue and their secretions, ie adipokines, is beginning to be recognized. Plasma adipokine levels, which are modulated during obesity, could have "remote" effects on mammary carcinogenesis. Breast cancer cells are surrounded and locally influenced by an adipocyte microenvironment, which is probably more extensive in obese people. Hence, leptin appears to be strongly involved in mammary carcinogenesis and may contribute to the local pro-inflammatory mechanisms, especially in obese patients, who have increased metastatic potential and greater risk of mortality. This review presents the multifaceted role of leptin in breast cancer development and the different molecular pathways involved such as inflammation, oxidative stress and antitumor immunity.
Fichier non déposé

Dates et versions

hal-02635681 , version 1 (27-05-2020)

Identifiants

Citer

Laetitia L. Delort, Adrien Rossary, Marie-Chantal Farges, Marie-Paule M.-P. Vasson, Florence F. Caldefie-Chezet. Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. Life Sciences, 2015, 140, pp.37-48. ⟨10.1016/j.lfs.2015.04.012⟩. ⟨hal-02635681⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More